SUNLENCA LAUNCH

When SUNLENCA received FDA approval, it marked a huge milestone—Gilead’s first approval for Lenacapavir, a treatment specifically for people with HIV who are considered hard to treat. This was a major moment for a niche group of patients who often get overlooked, and the client needed to move fast to meet the moment.

With only a logo in place, we jumped into overdrive to create a full visual identity and campaign direction from the ground up. We designed a comprehensive brand look and feel, then applied it across launch assets like the patient brochure and a newly built website. Everything had to happen quickly and strategically—and we delivered a campaign that felt thoughtful, clear, and worthy of the product’s significance.